Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Dube Michael P | Oct 2, 2024 | Sell | 2,012 | $19.01 | $38,000 |
| Clark Eliana | Jul 1, 2024 | Sell | 405 | $22.93 | $9,300 |
| Verwiel Frank | Jun 17, 2024 | Sell | 1,505 | $25 | $38,000 |
| BASTA JAMES | Mar 4, 2024 | Sell | 2,297 | $32.99 | $76,000 |
| Clark Eliana | Mar 4, 2024 | Sell | 605 | $32.99 | $20,000 |
| Sepp-Lorenzino Laura | Jan 8, 2024 | Sell | 1,608 | $28.66 | $46,000 |
| Sepp-Lorenzino Laura | Jan 8, 2024 | Sell | 667 | $29.38 | $20,000 |
| LEONARD JOHN M | Jan 3, 2024 | Sell | 19,223 | $29.46 | $570,000 |
| Lebwohl David | Jan 3, 2024 | Sell | 5,843 | $29.46 | $170,000 |
| Sepp-Lorenzino Laura | Jan 3, 2024 | Sell | 5,532 | $29.46 | $160,000 |
| Goddard Glenn | Jan 3, 2024 | Sell | 5,365 | $29.46 | $160,000 |
| Hicks Derek | Jan 3, 2024 | Sell | 3,877 | $29.46 | $110,000 |
| BASTA JAMES | Jan 3, 2024 | Sell | 3,805 | $29.46 | $110,000 |
| Clark Eliana | Jan 3, 2024 | Sell | 4,301 | $29.46 | $130,000 |
| Clark Eliana | Jan 3, 2024 | Sell | 307 | $30.12 | $9,200 |
| Bhanji Muna | Oct 31, 2023 | Sell | 265 | $23.9 | $6,300 |
| Bhanji Muna | Jul 31, 2023 | Sell | 265 | $42.33 | $11,000 |
| Bhanji Muna | Jul 6, 2023 | Sell | 1,867 | $39.3 | $73,000 |
| Clark Eliana | Jul 3, 2023 | Sell | 360 | $40.51 | $15,000 |
| Clark Eliana | Jun 20, 2023 | Sell | 5,000 | $45 | $230,000 |
| BASTA JAMES | Mar 2, 2023 | Sell | 1,088 | $43.88 | $48,000 |
| Sepp-Lorenzino Laura | Jan 5, 2023 | Sell | 1,641 | $38.22 | $63,000 |
| Sepp-Lorenzino Laura | Jan 5, 2023 | Sell | 689 | $39.1 | $27,000 |
| Sepp-Lorenzino Laura | Jan 4, 2023 | Sell | 2,508 | $37.21 | $93,000 |
| LEONARD JOHN M | Jan 4, 2023 | Sell | 6,673 | $37.21 | $250,000 |
| Hicks Derek | Jan 4, 2023 | Sell | 1,812 | $37.21 | $67,000 |
| Lebwohl David | Jan 4, 2023 | Sell | 2,574 | $37.21 | $96,000 |
| Goddard Glenn | Jan 4, 2023 | Sell | 2,427 | $37.21 | $90,000 |
| Clark Eliana | Jan 4, 2023 | Sell | 1,692 | $37.21 | $63,000 |
| BASTA JAMES | Jan 4, 2023 | Sell | 1,138 | $37.21 | $42,000 |
| Clark Eliana | Jan 3, 2023 | Sell | 231 | $34.48 | $8,000 |
What's the latest insider transaction for Intellia Therapeutics?
The most recent insider transaction for Intellia Therapeutics was conducted by Dube Michael P, who sold 2,012 shares on October 2, 2024 at a price of $19.01 per share.
Which insider has sold the most NTLA stock over the last two years?
LEONARD JOHN M has sold the most NTLA stock in the last 2 years, with a total value of $810,000.
What is the total value of insider transactions for Intellia Therapeutics (NTLA) in the last 2 years?
The total value of insider transactions for Intellia Therapeutics in the last 2 years is negative, amounting to -$2.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Intellia Therapeutics' market confidence?
Over the last 2 years, insider transactions for Intellia Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
